Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 80 (1) , 112-118
- https://doi.org/10.1016/0016-5085(81)90200-6
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Comparison of rate of Hepatic Metabolismin vitroand Half-Life for Antipyrinein vivoin Three SpeciesXenobiotica, 1979
- Multiplicity of hepatic cytochrome P-450 in intact microsomes: Effect of 3-methylcholanthrene inductionGeneral Pharmacology: The Vascular System, 1977
- Multiplicity of hepatic cytochrome P-450 in intact microsomes: Effect of phenobarbital inductionGeneral Pharmacology: The Vascular System, 1977
- Impairment of drug metabolism in patients with liver cancerEuropean Journal of Clinical Investigation, 1977
- Drug Disposition in Liver DiseaseNew England Journal of Medicine, 1977
- Pharmacokinetics in the ElderlyClinical Pharmacokinetics, 1976
- Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.Published by Wiley ,1975
- Clearance of Antipyrine‐Dependence of Quantitative Liver FunctionEuropean Journal of Clinical Investigation, 1974
- Relationship between Plasma Antipyrine Half-Lives and Hepatic Microsomal Drug Metabolism in DogsPharmacology, 1973
- MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN*Annals of the New York Academy of Sciences, 1971